oxandrolone
← Previous: oxabolone | 🏠 All Substances | 📊 Complete Table | Next: oxazepam →
OPSS Properties
| Classifications | 6000 |
| DEA Schedule | Schedule III |
| Reason | Controlled substance: Schedule III |
| Also Known As |
|
| Prohibited Because | DEA Controlled Substance List: Schedule III (DEA Controlled Substance List: Schedule III) WADA S1: Anabolic Agents (WADA Prohibited List S1: Anabolic Agents) |
| Added to Database | December 30, 2025 |
| Source Last Updated | July 17, 2024 |
| GUID | 85c1ad0b-2606-4b60-9403-e7a205962b8e |
External Resources
- FDA UNII Search
- GSRS Full Record
- NCATS Inxight Drugs
- CAS Common Chemistry
- PubChem
- EPA CompTox Dashboard
UNII: 7H6TM3CT4L · CAS: 53-39-4
PubChem Properties
Chemical Structure
Interactive 3D Structure
| Molecular Formula | C19H30O3 |
| Molecular Weight | 306.4 g/mol |
| IUPAC Name | (1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one |
| InChIKey | QSLJIVKCVHQPLV-PEMPUTJUSA-N |
📊 Complete Table | 🏠 All Substances
Substance 671 of 880